Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1422 studies found for:    "Anticoagulants"
Show Display Options
Rank Status Study
1 Completed Anticoagulant Clinics and Vitamin K Antagonists
Condition: Blood Coagulation Disorders
Intervention: Drug: Anticoagulant (warfarin, acenocoumarol, fluindione)
2 Active, not recruiting D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Other: Discontinue anticoagulant therapy (Negative d-dimer);   Other: Continue on anticoagulant therapy (positive d-dimer)
3 Recruiting Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Condition: Ischemic Stroke
Intervention: Drug: oral anticoagulants
4 Recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis;   Other Heart or Peripheral Vascular Diseases Leading to Chronic Anticoagulation
Interventions: Drug: Anticoagulants;   Drug: anticoagulants
5 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
6 Active, not recruiting Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
7 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
8 Completed Assays for and Reversal of New Anticoagulants
Conditions: Atrial Fibrillation;   Osteoarthritis of the Knee;   Osteoarthritis of the Hip
Intervention:
9 Not yet recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
10 Completed Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
Condition: Retinal Detachment
Intervention:
11 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
12 Completed Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
Condition: Thrombosis, Venous
Interventions: Drug: dalteparin;   Drug: enoxaparin;   Drug: fondaparinux;   Drug: unfractionated heparin
13 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
14 Terminated Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
Condition: Infection; Dialysis Catheter
Interventions: Drug: NAC/Tigecycline/Heparin combination lock solution;   Drug: Standard anticoagulant (Heparin or Citrate)
15 Suspended Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
Condition: Colon Cancer
Intervention: Drug: recombinant nematode anticoagulant protein c2 (rNAPc2)
16 Completed Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
Condition: Bleeding
Intervention: Drug: Antithrombotics
17 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
18 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
19 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
20 Completed Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
Conditions: Sinusoidal Obstruction Syndrome;   Colorectal Liver Metastases
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years